Announcement Under Regulation 30 (LODR)- Supply Agreement
Filed with BSE · · 2 pages · English
Summary by 6ix AI
Novelix Pharmaceuticals Ltd has announced a supply agreement with axabio® NV, a Belgian biotechnology company, for the procurement of natural astaxanthin derived from microalgae. The agreement, effective from a specified date, is expected to contribute significantly to the company's revenue and strengthen its product portfolio. This filing serves to inform stakeholders about the details of the agreement as required under regulatory obligations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Novelix Pharmaceuticals Ltd on 6ix
Earlier from Novelix Pharmaceuticals
- Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Wednesday, 11Th November, 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Novelix Pharmaceuticals Ltd Press Release Sep 30 2026
- Closure of Trading Window
Follow Novelix Pharmaceuticals into a list and get an email when it puts out news.
Follow Novelix Pharmaceuticals